As tirzepatide promotes substantial weight reductionclinical trials such as SURMOUNT-1 demonstrated average weight loss of approximately 20.9% of body weight at the 15 mg dose in adults without diabetesthis metabolic shift can influence the hypothalamic-pituitary-ovarian axis that regulates menstruation
That works at first, but the hidden cost is fragmentation: when reactions recur or change during dose escalation, patterns get missed, delays in clinician decisions occur, and anxiety spikes because nobody can show a clean, time-stamped record
doi:10.1136/bmjgast-2019-000302 106Tofacitinib (Xeljanz): new measures to minimise risk of venous thromboembolism and of serious and fatal infections
Similarly, effects on children and adolescents are unknown, and use in these populations cannot be recommended
If tolerance is good and no adverse effects occur, increase to 75mg daily, often split into two doses of approximately 37.5mg each
Weight loss journeys can often be emotionally challenging